DAVID CAMPOLA: Open Payments
NPI 1043217730 · NEW HARTFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$519 in 27 payments from 11 companies in 2025. Trend: 2023 $1,752 · 2024 $1,161 · 2025 $519
Food & beverage: $519
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $145 |
| GlaxoSmithKline, LLC. | 4 | $78 |
| PFIZER INC. | 3 | $61 |
| Lilly USA, LLC | 3 | $53 |
| Xeris Pharmaceuticals, Inc. | 2 | $45 |
| Novo Nordisk Inc | 2 | $37 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Almatica Pharma LLC | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Amgen Inc. | 1 | $16 |
Products named: BOTOX, SHINGRIX, NURTEC ODT, KEVEYIS, Wegovy, MOUNJARO, Auvelity, LOREEV XR.
Industry payments across NY — which companies pay providers there.
